Abstract:Autophagy, the bulk intracellular degradation of cytoplasmic constituents, can be a pro-survival or a pro-death mechanism depending on the context. A recent study showed that autophagy was activated in the phase of early brain injury following subarachnoid hemorrhage (SAH). However, whether autophagy activation after SAH is protective or harmful is still elusive. This study was undertaken to determine the potential role of autophagy pathway activation in early brain injury following SAH. The rats were pretreated with intracerebral ventricular infusion of either the autophagy inducer rapamycin (RAP) or inhibitor 3-methyladenine (3-MA) before SAH onset. The results from electron microscopic examinations showed that RAP administration caused the formation of autophagosomal vacuoles, and 3-MA induced neuronal apoptosis. RAP treatment significantly increased the expression of autophagic proteins Atg5 and Beclin 1, the ratio of microtubule-associated protein 1 light chain 3 (LC3)-II to LC3-I and reduced caspase-3 activity, the number of terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL)-positive cells, brain edema and neurological deficits after SAH. Conversely, 3-MA treatment exacerbated early brain injury. RAP treatment significantly increased the expression of the autophagic proteins Atg5 and Beclin 1, the ratio of LC3-II to LC3-I and reduced caspase-3 activity, the number of TUNEL-positive cells, brain edema and neurological deficits after SAH. Conversely, 3-MA treatment reversed these changes and exacerbated early brain injury. To further clarify the mechanism of autophagy protection, we investigated the expression levels of key apoptosis-related molecules. The results showed that RAP administration decreased Bax translocation to the mitochondria and downstream cytochrome c release from the mitochondria to the cytosol. Taken together, our study indicates that activation of autophagic pathways reduces early brain injury after SAH. This neuroprotective effect is likely exerted by anti-apoptotic mechanisms.

Role of rapamycin in protection against cerebral ischemia-induced brain injury is related to neurogenesis in discrete brain regions in rat

Study on the Protective Effects of Rapamycin on Cerebral Ischemia-Reperfusion Injury in Rats

Rapamycin Prevents Cerebral Stroke by Modulating Apoptosis and Autophagy in Penumbra in Rats

Rapamycin Alleviates Neuronal Injury and Modulates Microglial Activation After Cerebral Ischemia

The Post-Therapeutic Effect of Rapamycin in Mild Traumatic Brain-Injured Rats Ensuing in the Upregulation of Autophagy and Mitophagy.

Inhibition of Mtor Pathway by Rapamycin Reduces Brain Damage in Rats Subjected to Transient Forebrain Ischemia

Rapamycin Reduced Ischemic Brain Damage in Diabetic Animals is Associated with Suppressions of Mtor and ERK1/2 Signaling

Rapamycin ameliorates brain damage and maintains mitochondrial dynamic balance in diabetic rats subjected to middle cerebral artery occlusion

Rapamycin attenuates mitochondrial dysfunction via activation of mitophagy in experimental ischemic stroke

Autophagy Activation is Associated with Neuroprotection Against Apoptosis Via a Mitochondrial Pathway in a Rat Model of Subarachnoid Hemorrhage

The Role of Autophagic and Lysosomal Pathways in Ischemic Brain Injury.

Inhibition of the JAK2/STAT3 Pathway and Cell Cycle Re-Entry Contribute to the Protective Effect of Remote Ischemic Pre-Conditioning of Rat Hindlimbs on Cerebral Ischemia/reperfusion Injury.

Neuronal Injury in Rat Model of Permanent Focal Cerebral Ischemia is Associated with Activation of Autophagic and Lysosomal Pathways.

Rapamycin Enhances Mitophagy and Attenuates Apoptosis after Spinal Ischemia-Reperfusion Injury.

Central action of rapamycin on early ischemic injury and related cardiac depression following experimental subarachnoid hemorrhage

Rapamycin Induces Autophagy to Alleviate Acute Kidney Injury Following Cerebral Ischemia and Reperfusion Via the Mtorc1/atg13/ulk1 Signaling Pathway

Therapeutic Effect of Rapamycin on TDP-43-Related Pathogenesis in Ischemic Stroke

Autophagy activation is associated with neuroprotection in a rat model of focal cerebral ischemic preconditioning.

Inhibition of Mammalian Target of Rapamycin Attenuates Early Brain Injury Through Modulating Microglial Polarization after Experimental Subarachnoid Hemorrhage in Rats

Inhibition of Mtor Signaling Confers Protection Against Cerebral Ischemic Injury in Acute Hyperglycemic Rats.

Neuroprotective Effect of Rapamycin on Spinal Cord Injury Via Activation of the Wnt/β-catenin Signaling Pathway.